← FDA Drug Approvals (Drugs@FDA)
CLOBAZAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2020-01-31
Drug application
- FDA Application #
ANDA211032- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOBAZAM
- Generic name
- Clobazam
- Active ingredients
- CLOBAZAM
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA
- First approval
- 2020-01-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown